跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
合贝爽 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Diltiazem Hydrochloride for Injection
Approved
化学药品
Diltiazem Hydrochloride for Injection
MITSUBISHI TANABE PHARMA CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Nov 17, 2020
Approval ID
8884Y9Moo8J
Company
MITSUBISHI TANABE PHARMA CORPORATION
Type
化学药品
Approval Details
Approval Id
8884Y9Moo8J
Approval Number
国药准字HJ20160287
Generic Name
注射用盐酸地尔硫䓬
Generic Name En
Diltiazem Hydrochloride for Injection
Trade Name
合贝爽
Drug Type
化学药品
Dosage Form
注射剂
Strength
10mg
Reg Date
2020-11-17
Expired Date
2025-11-16
Company Name
MITSUBISHI TANABE PHARMA CORPORATION
Company Detail Path
/organization/mitsubishi-tanabe-pharma-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 17, 2020
Approval ID
8884Y9Moo8J
Type
化学药品
Back to NMPA Approvals